Josh C. Woloszynek, Ph.D.
Affiliations: | 2007 | Washington University, Saint Louis, St. Louis, MO |
Area:
Molecular geneticsGoogle:
"Josh Woloszynek"Mean distance: 21373.2 (cluster 6)
Parents
Sign in to add mentor| Mark S. Sands | grad student | 2007 | Washington University | |
| (Adipose storage deficiency in lysosomal storage disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Babcock MC, Mikulka CR, Wang B, et al. (2021) Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor. Scientific Reports. 11: 14486 |
| Li Y, Xu Y, Benitez BA, et al. (2019) Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target. Proceedings of the National Academy of Sciences of the United States of America |
| Woloszynek JC, Kovacs A, Ohlemiller KK, et al. (2009) Metabolic adaptations to interrupted glycosaminoglycan recycling. The Journal of Biological Chemistry. 284: 29684-91 |
| Sands M, Woloszynek J, Ohlemiller K, et al. (2009) 120. Metabolic and clinical adaptations to interrupted lysosomal recycling Molecular Genetics and Metabolism. 96: S38 |
| Woloszynek JC, Coleman T, Semenkovich CF, et al. (2007) Lysosomal dysfunction results in altered energy balance. The Journal of Biological Chemistry. 282: 35765-71 |
| Woloszynek JC, Roberts M, Coleman T, et al. (2004) Numerous transcriptional alterations in liver persist after short-term enzyme-replacement therapy in a murine model of mucopolysaccharidosis type VII. The Biochemical Journal. 379: 461-9 |